CClinicalTrials.gg
CompletedNCT02890680Updated Apr 12, 2017

Effects of the Use of Platelet-rich Fibrin on Bone Regeneration After Impacted Third Molar Surgery

An interventional study of Platelet-rich fibrin and Control group in Fibrin/Therapeutic Use, Blood Platelets and Molar, Third, sponsored by Rio de Janeiro State University. Completed at 1 site in Brazil. Open to participants aged 16 Years to 29 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2017-04-12.

Sponsored by Rio de Janeiro State University · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
20
Allocation
Randomized
Ages
16 Years to 29 Years
Sex
All
01

Study summary

The purpose of this study is to evaluate the bone regeneration after impacted third molar surgery on split mouth design using platelet-rich fibrin.

02

Conditions studied

  • Fibrin/Therapeutic Use
  • Blood Platelets
  • Molar, Third
  • Bone Regeneration

Browse trials for

Keywords

  • platelet-rich fibrin
  • third molar
  • bone regeneration
03

In context

Tooth, Impacted

195 studies on the registry are indexed under Tooth, Impacted; 20 are open to participants now.

This study's enrollment of 20 is below the median of 53 across 164 interventional studies indexed under Tooth, Impacted.

Browse Tooth, Impacted studies →

Lead sponsor

Rio de Janeiro State University is the lead sponsor of 62 studies on the registry; 6 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
16 Years to 29 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • Healthy patients
  • Preoperative platelet count higher than 150,00/ mm3
  • Patient who required bilateral mandibular third molar extractions

Exclusion criteria

Exclusion Criteria:

  • Smokers patients
  • Alcoholics patients
  • Patients whom the inferior second molar was missing
  • Patients who had acute pericoronitis on the inferior third molar
  • Severe periodontal disease
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Triple (Participant, Investigator, Outcomes assessor)
Enrollment
20 participants (actual)

Study arms

  • Experimental
    Platelet-rich fibrin group

    Use platelet-rich fibrin after mandibular third molar extraction

    Procedure: Platelet-rich fibrin

  • Placebo comparator
    Control group

    mandibular third molar extraction

    Procedure: Control group

Interventions

  • ProcedurePlatelet-rich fibrin
  • ProcedureControl group
06

What researchers measure

Primary outcomes

  1. Change in bone density through tomography evaluation

    Time frame: Change from Baseline bone measurement at three months after surgery

Secondary outcomes

  1. Change in periodontal-probing depth measurement on distal aspect of the second molar through Clinical evaluation

    Time frame: Change from baseline at 3 months after surgery

  2. Pain through Visual Analogue Scale

    Time frame: 1st day after surgery

  3. Pain through Visual Analogue Scale

    Time frame: 3rd day after surgery

  4. Pain through Visual Analogue Scale

    Time frame: 7th day after surgery

  5. Soft tissue healing through Clinical evaluation numeric scale

    Time frame: 7th day after surgery

07

Study locations

1 site
  • João Canellas
    Rio de Janeiro, 24240170, Brazil
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 12, 2017, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT02890680
Lead sponsor
Rio de Janeiro State University
Responsible party
João Vitor dos Santos Canellas, DDS MS (MSc, Rio de Janeiro State University) — Principal investigator
First posted
Sep 7, 2016
Start date
Aug 2016
Primary completion
Nov 2016
Completion
Jan 2017
Last update
Apr 12, 2017

Study contacts

João Vitor Canellas, DDS; MSc
principal investigator · Rio de Janeiro University State

Oversight

Data monitoring committee
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Apr 2017. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion